MarketCap
Facebook
X
TelegramAlexion Pharmaceuticals, Inc. P/S Ratio 2011-2026 | ALXN
Annual P/S Ratio Alexion Pharmaceuticals, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 5.53 | 4.49 | 6.54 | 7.71 | 9.3 | 12 | 16.3 | 20.4 | 16 | 17.5 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 20.4 | 4.49 | 11.6 |
P/S Ratio of other stocks in the Biotechnology industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M |  Germany |
 |
I-Mab
IMAB
|
94.1 | - | - | $ 866 M |  China |
 |
Adagene
ADAG
|
35.6 | $ 2.75 | -5.5 % | $ 155 M | China |
 |
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M |  USA |
 |
Alterity Therapeutics Limited
ATHE
|
131 | $ 3.17 | -2.76 % | $ 7.63 B |  Australia |
 |
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | USA |
 |
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M |  Canada |
 |
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | USA |
 |
Akebia Therapeutics
AKBA
|
1.32 | $ 1.42 | -2.07 % | $ 266 M | USA |
 |
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - |  Russia |
 |
Ascendis Pharma A/S
ASND
|
947 | $ 225.36 | 0.63 % | $ 5 B |  Danmark |
 |
Amgen
AMGN
|
4.68 | $ 342.65 | -0.08 % | $ 184 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | USA |
 |
ANI Pharmaceuticals
ANIP
|
1.95 | $ 81.6 | -0.49 % | $ 1.58 B | USA |
 |
BioNTech SE
BNTX
|
35.7 | $ 114.18 | -2.22 % | $ 27.2 B | Germany |
 |
Burford Capital Limited
BUR
|
6.35 | $ 9.67 | 0.16 % | $ 1.52 B | Britain |
 |
Aravive
ARAV
|
6.61 | - | -13.39 % | $ 1.45 M | USA |
 |
Arrowhead Pharmaceuticals
ARWR
|
7.54 | $ 70.74 | 2.34 % | $ 9.46 B | USA |
 |
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | Canada |
 |
Autolus Therapeutics plc
AUTL
|
1.37 K | $ 1.38 | -3.85 % | $ 352 M | Britain |
 |
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | USA |
 |
Aytu BioScience
AYTU
|
0.237 | $ 2.63 | 1.74 % | $ 16.5 M | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
34 | - | -15.15 % | $ 60.3 M | Britain |
 |
Brickell Biotech
BBI
|
1.42 | - | -5.38 % | $ 6.06 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
759 | $ 4.05 | -1.22 % | $ 8.81 B |  Israel |
 |
Amneal Pharmaceuticals
AMRX
|
0.654 | $ 13.65 | -3.3 % | $ 4.22 B | USA |
 |
AIkido Pharma
AIKI
|
1.08 | - | 1.93 % | $ 17.4 M | USA |
 |
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | Germany |
 |
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | USA |
 |
BioCryst Pharmaceuticals
BCRX
|
3.81 | $ 6.58 | -1.35 % | $ 1.36 B | USA |
 |
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | USA |
 |
Beam Therapeutics
BEAM
|
39.4 | $ 27.94 | -4.61 % | $ 2.3 B | USA |
 |
BeiGene, Ltd.
BGNE
|
66.4 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Biogen
BIIB
|
2 | $ 178.24 | 1.2 % | $ 26 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | Israel |